Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual triggering vs HCG alone for ovulation in POSEIDON group 4 IVF cycles
IRCT20201121049457N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of human chorionic gonadotropin in female infertility (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Oocyte maturation rate and Clinical pregnancy rate. Started Apr 2024; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT20201121049457N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201121049457N2.